Viracta Therapeutics Inc (VIRX)
0.222
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
0.21
-0.01
(-5.41%)
After-Hours: 20:00
Viracta Therapeutics Cash and Short Term Investments (Quarterly): 30.00M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 30.00M |
| March 31, 2024 | 39.57M |
| December 31, 2023 | 53.69M |
| September 30, 2023 | 62.95M |
| June 30, 2023 | 72.87M |
| March 31, 2023 | 80.33M |
| December 31, 2022 | 91.04M |
| September 30, 2022 | 77.07M |
| Date | Value |
|---|---|
| June 30, 2022 | 83.14M |
| March 31, 2022 | 92.20M |
| December 31, 2021 | 103.55M |
| September 30, 2021 | 110.98M |
| June 30, 2021 | 122.72M |
| March 31, 2021 | 129.18M |
| December 31, 2020 | 47.09M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
30.00M
Minimum
Jun 2024
129.18M
Maximum
Mar 2021
79.76M
Average
80.33M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.751M |
| Palatin Technologies Inc | 10.01M |
| iBio Inc | 14.21M |
| Theriva Biologics Inc | 16.59M |
| Oragenics Inc | 1.349M |